Open

Radiation Trial for High Risk Prostate Cancer

In this study, we want to learn if decreasing or increasing your radiation and hormonal therapy has an effect on high risk prostate cancer.

Age & Gender

18 years ~ 99 years
Male

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina

What will be asked of you

During this study, you will receive physical exams, blood tests, pelvic scans, bone density scans if needed, along with the study-required radiation and hormonal treatment. You will be asked to complete questionnaires at some visits.

In-person visits:
10 or more

Total length of participation:
5 years

Looking for Specific Volunteers

Able to participate:

You have high risk prostate cancer

Not eligible if:

Your cancer has metastasized
You have had your prostate removed
You have previously had radiation in the region of your cancer

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Rex Cancer Center
2901 Blue Ridge Rd, Raleigh, NC 27607, USA

Secondary Visit Location

Rex Cancer Center of Wakefield
11200 Governor Manly Way Raleigh NC 27614

Additional Study Information

Principal Investigator

Gregg Goldin
UNC Hospitals - Rex

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Prostate)
Men's Health

IRB Number

23-1622

ClinicalTrials.gov

04513717

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.